Supraflex Cruz evidence presented at TCT 2025
In November 2025, EUKON shared an update from Sahajanand Medical…
SUPRAFLEX-TALENT trial 3yr follow-up has been presented at EuroPCR 2021
At EuroPCR 2021 TALENT 3yrs follow up has been presented. Supraflex stent showed to be as safe and effective as Xience family stent in all-comers population.
Latest News:
LaaGuarder: first European clinical use announced by EUKON
In January 2026, EUKON announced the first clinical use in…
Supraflex Cruz NEVO now available to Italian cath labs
EUKON announced the availability of Supraflex Cruz NEVO to Italian…